Cargando…
Hydroxyethyl starch in severe sepsis: end of starch era?
EXPANDED ABSTRACT: CITATION: Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB...
Autores principales: | Estrada, Carlos A, Murugan, Raghavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672539/ https://www.ncbi.nlm.nih.gov/pubmed/23509901 http://dx.doi.org/10.1186/cc12531 |
Ejemplares similares
-
‘To prone or not to prone’ in severe ARDS: questions answered, but others remain
por: Tekwani, Seema S, et al.
Publicado: (2014) -
Hydrocortisone infusion may improve survival in patients with severe community-acquired pneumonia
por: Raghavan, Murugan, et al.
Publicado: (2005) -
Dexmedetomidine use in the ICU: Are we there yet?
por: Ahmed, Shakeel, et al.
Publicado: (2013) -
Neuromuscular blockers and ARDS: Thou shalt not breathe, move, or die!
por: Yegneswaran, Balaji, et al.
Publicado: (2011) -
Stenting versus aggressive medical therapy for intracranial arterial stenosis: more harm than good
por: Al Hasan, Muthanna, et al.
Publicado: (2012)